NCT03063788 is a Phase 1 clinical trial of 3BNC117-Copper-64 in HIV, sponsored by Bayside Health.

Who is sponsoring NCT03063788?

NCT03063788 is sponsored by Bayside Health.

What drugs are being tested in NCT03063788?

Interventions in NCT03063788: 3BNC117-Copper-64.

Is NCT03063788 still recruiting?

NCT03063788 is currently completed. Last updated 24 June 2020.

Last reviewed 2020-06-24 · How we verify

NCT03063788

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Imaging the HIV Reservoir

Completed Phase 1 Last updated 24 June 2020

What this trial tests

Phase 1 trial testing 3BNC117-Copper-64 in HIV in 17 participants. Completed in 1 April 2020.

Timeline

18 September 2018

Primary endpoint
1 February 2020

1 April 2020

Quick facts

Lead sponsor	Bayside Health
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	sequential
Masking	none
Primary purpose	diagnostic
Enrollment	17
Start date	18 September 2018
Primary completion	1 February 2020
Estimated completion	1 April 2020
Sites	1 location across Australia

Drugs / interventions tested

3BNC117-Copper-64 — full drug profile →

Conditions studied

HIV — all drugs for HIV →

Sponsor

Bayside Health — full company profile →

Who can join

Adults 18 to 65, any sex, with HIV. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Radiolabelling broadly neutralizing anti-HIV antibody 3BNC117 with a Copper-64 radio isotope for infusion into people with HIV followed by MRI/PET scanning to detect HIV in vivo.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Barriers and strategies to achieve a cure for HIV.
Pitman MC, Lau JSY, McMahon JH, Lewin SR. · · 2018 · cited 99× · PMID 29893245 · DOI 10.1016/s2352-3018(18)30039-0
Clinical trials of broadly neutralizing monoclonal antibodies in people living with HIV - a review.
Mahomed S, Pillay K, Hassan-Moosa R, Galvão BPGV, et al · · 2025 · cited 20× · PMID 40189566 · DOI 10.1186/s12981-025-00734-8
A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls.
McMahon JH, Zerbato JM, Lau JSY, Lange JL, et al · · 2021 · cited 18× · PMID 33640794 · DOI 10.1016/j.ebiom.2021.103252

Verify or expand the search:

Other recruiting trials for HIV

Currently open trials in the same condition.

NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
NCT07221214 — GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV · Phase 2 · recruiting
NCT07226128 — The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV · NA · recruiting
NCT07390474 — Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA i · Phase 1 · recruiting
NCT07390955 — A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1 · Phase 1 · recruiting

Other Bayside Health trials

Trials by the same sponsor.

NCT05852301 — Optimising Cohorts for HIV Cure Interventions · unknown
NCT05470816 — Tranexamic Acid to Reduce Delirium After Gastrointestinal Surgery: the TRIGS-D Trial · Phase 3 · active not recruiting
NCT04192435 — Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery · Phase 4 · completed
NCT04978285 — Association of Postoperative Anaemia With Patient-centred Outcomes · completed
NCT03869736 — Nitrous Oxide for the Treatment of Major Depressive Disorder · Phase 2 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03063788 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bayside Health
Last refreshed: 24 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03063788.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing